ARWR — Arrowhead Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual balance sheet for Arrowhead Pharmaceuticals, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th	2025 September 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	368	376	396	677	917
Net Total Accounts Receivable
Net Total Receivables	10.3	1.41	0	—	6.82
Prepaid Expenses
Total Other Current Assets
Total Current Assets	385	405	420	695	951
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	66	169	336	431	426
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	710	692	766	1,140	1,385
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	147	139	105	103	195
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	301	293	494	954	919
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	409	399	271	185	466
Total Liabilities & Shareholders' Equity	710	692	766	1,140	1,385
Total Common Shares Outstanding